Shares of Compass Inc. turned higher after a Wall Street Journal report that the real-estate brokerage is in talks to buy ...

According to data from S&P Global Market Intelligence, the stock was up 15% for the week as of Friday at 2:14 p.m. ET. Image source: Compass. Revenue soared 25.9% in Q4 to $1.38 billion ...

Shares of real estate technology company Compass (NYSE:COMP ... we wrote about over the last year was 10 months ago when the stock gained 18.6% on the news that the company reported first quarter ...

Compass recently integrated all seven of the fully owned Title and Escrow (T&E) operations into their Compass platform. More real estate transactions utilizing the in-house T&E services in the ...

As such, the Zacks rating upgrade for Compass Therapeutics, Inc. is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price. The change in a ...

Shares of Compass Therapeutics (NASDAQ:CMPX) were up 8% in afternoon trading Monday after Guggenheim initiated coverage of the stock with a buy rating ahead of upcoming data for the company's drug ...

COMPASS ($COMP) posted quarterly earnings results on Tuesday, February 18th. The company reported earnings of -$0.08 per share, beating estimates of -$0.09 by $0.01 ...

If Compass can reach GAAP profitability, it could have a lot of upside. The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now ...

But moves this big are rare even for Compass and indicate this news significantly impacted the market’s perception of the business. The biggest move we wrote about over the last year was 10 months ago ...

Compass posted strong growth in its fourth-quarter ... According to data from S&P Global Market Intelligence, the stock was up 15% for the week as of Friday at 2:14 p.m. ET. Revenue soared 25.9 ...